Companies House · 01497267

BIOGEN IDEC LIMITED

UK registered company, private limited company, incorporated 19 May 1980.

Active
40
Public contracts
0
Spend payments
Total spend

BIOGEN IDEC LIMITED is a UK company registered at Companies House under number 01497267. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
01497267
Status
Active
Company type
Private Limited Company
Incorporated
19 May 1980
Country of origin
United Kingdom
Registered office
BUILDING 5 FOUNDATION PARK, MAIDENHEAD, BERKSHIRE, SL6 3UD, ENGLAND
Nature of business (SIC)
46180 - Agents specialized in the sale of other particular products
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to BIOGEN IDEC LIMITED.

ProcurementBuyerAwardedValue
NP33923 RanibizumabThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Nusinerin (Spinraza)BELFAST HEALTH AND SOCIAL CARE TRUST
Transitional Drugs 3Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts
Cytokine ModulatorsThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Cytokine ModulatorsThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Cytokine ModulatorsThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Interferon Beta-1a (Avonex®)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Interferon Beta-1a (Avonex®)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Interferon Beta-1a (Avonex®)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Procurement of Nusinerin (Spinraza) from Biogen Idec LtdBELFAST HEALTH AND SOCIAL CARE TRUST
Proprietary DrugsVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)
Biologic and Biosimilar MedicineseTenderwales
Proprietary DrugseTenderwales
NP47822 Multiple Sclerosis MedicinesThe Common Services Industry (more commonly known as NHS National Services Scotland) ("NSS")
Medicinal Products Dynamic Purchasing System (131864)Regional Business Services Organisation, Procurement and Logistics Service
NP47923a Adalimumab, NP47923b Tocilizumab and NP47923c EculizumabThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP47823b Multiple Sclerosis Medicines AdditionsThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024NHS England
NP47924 Cytokine ModulatorsThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP47924 Cytokine ModulatorsThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP47825 Multiple Sclerosis MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Branded and Biosimilar OphthalmologyThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Medicinal Products and Pharma Funded Homecare Services (5315742) - Pre - Market EngagementRegional Business Services Organisation Procurement and Logistics Service
Medicinal Products and Pharma Funded Homecare Services (5315742) - Pre - Market EngagementRegional Business Services Organisation Procurement and Logistics Service
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
Biosimilars and Biologics with Associated Medicines Homecare ServicesVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025NHS England North East & Yorkshire30 Jul 2025£688.8m
NHS Framework, North of England, Branded Medicines-Tranche A and Annual TrancheNHS England11 Feb 2021£1
NHS Framework for the Midlands and East, Branded Medicines - Tranche BNHS England25 Jan 2021£228.2m
NHS Midlands and East Branded Medicines - Tranche ANHS England15 Jan 2020£418.8m
NHS Framework Agreement for Branded Medicines - NationalNHS England30 Apr 2019£1.4bn
NHS England - Midlands and East Branded Medicines - Tranche BNHS England17 Jan 2019£295m
NHS England - Midlands and East Branded Medicines - Tranche BNHS England17 Jan 2019£295m
NHS England - Midlands and East Branded Medicines - Tranche BNHS England17 Jan 2019£295m
NHS England - Midlands and East Branded Medicines - Tranche BNHS England17 Jan 2019£295m
NHS National Framework Agreement for the Supply of AdalimumabNHS England1 Dec 2018£159.4m
NHS England Framework Agreement for Proprietary Pharmaceuticals: South of England (Tranche B)NHS England13 Sept 2018£501.4m
NHS Framework Agreement - North of England - Tranche BNHS England8 Jan 2018£521.1m

Supplier identities

How this company appears as a supplier across the data.

FAQs about BIOGEN IDEC LIMITED

Is BIOGEN IDEC LIMITED an active company?

BIOGEN IDEC LIMITED (company number 01497267) is recorded as "Active", incorporated on 19 May 1980.

What does BIOGEN IDEC LIMITED do?

Its Companies House nature-of-business (SIC) is: 46180 - Agents specialized in the sale of other particular products.

Has BIOGEN IDEC LIMITED won UK public-sector contracts?

Yes — 40 public-sector contract awards are linked to this company in our data.

Where is BIOGEN IDEC LIMITED based?

Its registered office is BUILDING 5 FOUNDATION PARK, MAIDENHEAD, BERKSHIRE, SL6 3UD, ENGLAND.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable